Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trautmann

Showing results (1231-1240 of 1,441) with videos related to

Pageof 145
Sort By:
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
Stem Cell Reports|August 5, 2022
Exclusive generation of rat spermatozoa in sterile mice utilizing blastocyst complementation with pluripotent stem cellsJoel Zvick, Monika Tarnowska-Sengül, Adhideb Ghosh, et al.
The Journal of General Physiology|September 23, 2022
Nerve-dependent distribution of subsynaptic type 1 inositol 1,4,5-trisphosphate receptor at the neuromuscular junctionPompeo Volpe, Alessandra Bosutti, Alessandra Nori, et al.
Annals of Hematology|February 25, 2025
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?Simone Karp, Karolin Trautmann-Grill, Paul Warncke, et al.
Haematologica|May 21, 2026
[<sup>18</sup>F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myelomaRaphael Teipel, Karolin Trautmann-Grill, Luisa Kleditsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
Leukemia|December 18, 2013
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersM Ladetto, M Brüggemann, L Monitillo, et al.
Physical Review Letters|May 7, 2003
First observation of atomic levels for the element fermium (Z=100)M Sewtz, H Backe, A Dretzke, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
International Journal of Cancer|June 19, 2015
SRC inhibition represents a potential therapeutic strategy in liposarcomaElisabeth Sievers, Marcel Trautmann, Dagmar Kindler, et al.
Pageof 145

Showing results (1231-1240 of 1,441) with videos related to

Sort By:
Pageof 145
Annals of Hematology|February 6, 2025
Functional apoptosis profiling reveals vulnerabilities in T-cell large granular lymphocytic leukemiaEvgenii Shumilov, Paolo Mazzeo, Marcel Trautmann, et al.
Stem Cell Reports|August 5, 2022
Exclusive generation of rat spermatozoa in sterile mice utilizing blastocyst complementation with pluripotent stem cellsJoel Zvick, Monika Tarnowska-Sengül, Adhideb Ghosh, et al.
The Journal of General Physiology|September 23, 2022
Nerve-dependent distribution of subsynaptic type 1 inositol 1,4,5-trisphosphate receptor at the neuromuscular junctionPompeo Volpe, Alessandra Bosutti, Alessandra Nori, et al.
Annals of Hematology|February 25, 2025
Is there still a place for autologous salvage transplantation in relapsed/refractory multiple myeloma in the era of novel therapies?Simone Karp, Karolin Trautmann-Grill, Paul Warncke, et al.
Haematologica|May 21, 2026
[<sup>18</sup>F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myelomaRaphael Teipel, Karolin Trautmann-Grill, Luisa Kleditsch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 23, 2017
FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid LiposarcomaMarcel Trautmann, Jasmin Menzel, Christian Bertling, et al.
Leukemia|December 18, 2013
Next-generation sequencing and real-time quantitative PCR for minimal residual disease detection in B-cell disordersM Ladetto, M Brüggemann, L Monitillo, et al.
Physical Review Letters|May 7, 2003
First observation of atomic levels for the element fermium (Z=100)M Sewtz, H Backe, A Dretzke, et al.
British Journal of Haematology|April 1, 2022
A phase II trial to evaluate the combination of pixantrone and obinutuzumab for patients with relapsed aggressive lymphoma: Final results of the prospective, multicentre GOAL trialGeorg Hess, Andreas Hüttmann, Mathias Witzens-Harig, et al.
International Journal of Cancer|June 19, 2015
SRC inhibition represents a potential therapeutic strategy in liposarcomaElisabeth Sievers, Marcel Trautmann, Dagmar Kindler, et al.
Pageof 145